Although the EU is thought of as a single market, the conditions for pharmaceutical distribution are complex and varied. There are 27 member states, 30 government healthcare authorities and  23 languages.   Stravencon prepares a comprehensive, customised market entry strategy for each Chinese partner, including product patent expiries, the competitive landscape, distribution, pricing and reimbursement schemes.